Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions

Liz Lewis

Fireside Chat: Patient-Centric Touchpoints: Structuring Oncology Treatment Around the Patient Journey

Takeda Oncology

Apr 12
Show Filter
8:00am - 9:00am 60 mins
Registration and Networking Breakfast
9:00am - 9:15am 15 mins
Welcome and Opening Remarks
  • Panelist Sharon Karlsberg - Principal, ZS Associates
  • Panelist Pawel Przewiezlikowski - CEO, Selvita
  • Panelist Aiman Shalabi - CMO, Cancer Research Institute
9:15am - 10:00am 45 mins
Lessons Learned from 2017
  • Panelist Pawel Przewiezlikowski - CEO, Selvita
  • Panelist Jon Roffman - Principal, ZS Associates
  • Panelist Bob Silverman - Personalized Health Care (PHC) Business Strategy and Partnering, Roche
  • Moderator John Beeler - VP Portfolio Strategy & Life Cycle Management, Inivata
10:00am - 10:45am 45 mins
Staying Bold in Clinical Innovation: Oncology Drug Development
  • Panelist Nathan Caffo - CEO & President, Presage Biosciences
  • Panelist Rachel Humphrey - CMO, CytomX
  • Panelist Sridhar Ramaswamy - VP, Translational Research & Development, Tesaro
  • Moderator Zhen Su - SVP & CMO, EMD Serono
10:45am - 11:15am 30 mins
Networking Break
11:15am - 12:15pm 60 mins
Novel Therapeutic Approaches in Oncology
  • Panelist Johan Pontin - CEO, the RNA Medicines Company
  • Panelist James Prudent, Ph.D. - CEO, Centrose
  • Panelist Rangaprasad Sarangarajan - SVP & CSO, BERG
  • Panelist Roman Yelensky - EVP & CTO, Gritstone Oncology
  • Moderator Chip Clark - CEO & President, Genocea Biosciences
12:15pm - 12:45pm 30 mins
Fireside Chat: Patient-Centric Touchpoints: Structuring Oncology Treatment Around the Patient Journey
  • Keynote Speaker Liz Lewis - Chief Counsel and Head of Patient Advocacy, Takeda Oncology
  • Moderator Pamela Contag - CEO, BioEclipse Therapeutics
12:45pm - 1:45pm 60 mins
Networking Lunch
1:45pm - 2:30pm 45 mins
Latest Developments in Combination Therapies
  • Panelist Sharon Karlsberg - Principal, ZS Associates
  • Panelist Matthew Price - EVP & COO, Phosplatin Therapeutics
  • Panelist Wenru Song - President and Head of R&D, Kira Pharmaceuticals
  • Panelist Elizabeth Trehu - CMO, Jounce Therapeutics
  • Moderator Lawrence Tamarkin - President & CEO, CytImmune
2:30pm - 3:15pm 45 mins
Immuno-Oncology: Challenges & Opportunities
  • Panelist Jennifer Buell - Chief Comunications & External Affairs Officer, Agenus
  • Panelist David Giljohann - CEO, Exicure
  • Panelist Jimmy Lin, MD, PhD, MHS - Founder and President, Rare Genomics Institute/Natera
  • Panelist Aiman Shalabi - CMO, Cancer Research Institute
  • Moderator Bertha Cheng - Senior Director, Huron Consulting Group
3:15pm - 3:45pm 30 mins
Networking Break
3:45pm - 4:30pm 45 mins
Discovery Stage and Pre-Clinical Combination Therapy
  • Panelist Pamela Contag - CEO, BioEclipse Therapeutics
  • Panelist Russell LaMontagne - President & CEO, Boston Immunetech
  • Panelist James Stamatis - VP Business Development & Acquisitions, AbbVie
  • Moderator Parker Cassidy - CCO, Mitra Biotech
4:30pm - 4:45pm 15 mins
Closing Remarks - Day One
4:45pm - 5:45pm 60 mins
Cocktails and Hors d'oeuvres